Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
28.34
+1.84 (6.94%)
At close: May 22, 2026, 4:00 PM EDT
27.99
-0.35 (-1.24%)
After-hours: May 22, 2026, 6:27 PM EDT
Assembly Biosciences Employees
Assembly Biosciences had 73 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
73
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$973,932
Profits / Employee
-$87,438
Market Cap
545.58M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Ginkgo Bioworks Holdings | 485 |
| ProKidney | 231 |
| Rigel Pharmaceuticals | 174 |
| Prime Medicine | 146 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
ASMB News
- 3 days ago - Assembly Biosciences announces expansion of ABI-6250 clinical development - TheFly
- 3 days ago - Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 3 days ago - Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases - GlobeNewsWire
- 11 days ago - Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference - MarketBeat
- 12 days ago - Assembly Biosciences Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026 - GlobeNewsWire
- 14 days ago - Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference - GlobeNewsWire
- 18 days ago - Assembly Biosciences reports Q1 EPS (54c), consensus (64c) - TheFly